ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

MLTX MoonLake Immunotherapeutics

45.26
2.69 (6.32%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
MoonLake Immunotherapeutics MLTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
2.69 6.32% 45.26 09:00:00
始値 安値 高値 終値 前日終値
43.51 43.405 45.465 45.26 42.57
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1020:00BWMoonLake Immunotherapeutics Inks Three-Year Technology..
2024/3/1121:01EDGAR2Form 8-K - Current report
2024/3/1101:00GLOBEMoonLake announces significant improvements with Nanobody®..
2024/3/0422:00GLOBEMoonLake Immunotherapeutics to present MIRA trial data of..
2024/3/0109:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0109:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2922:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2922:03EDGAR2Form 8-K - Current report
2024/2/2922:00GLOBEMoonLake Immunotherapeutics Reports Full Year 2023 Financial..
2024/2/2623:00EDGAR2Form 8-K - Current report
2024/2/2622:00GLOBEMoonLake Immunotherapeutics Announces Positive Feedback from..
2024/2/2406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2308:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2108:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1708:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1606:02EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1522:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:05EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2206:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:16EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2006:34EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1422:00GLOBEMoonLake Immunotherapeutics Reports Third Quarter 2023..
2023/11/0621:55EDGAR2Form 8-K - Current report
2023/11/0601:00GLOBEMoonLake Immunotherapeutics announces landmark Phase 2..
2023/10/1619:16EDGAR2Form 8-K - Current report
2023/10/1522:03GLOBEMoonLake Immunotherapeutics announces the full dataset from..
2023/10/1123:15GLOBEMoonLake Immunotherapeutics presents positive 12-week data..
2023/10/0420:01GLOBEPhase 2 MIRA primary analysis trial results (12-week) for..
2023/9/0620:00GLOBEMoonLake Immunotherapeutics to host a Capital Markets Day on..
2023/8/1020:00GLOBEMoonLake Immunotherapeutics Reports Second Quarter 2023..
2023/7/2521:00GLOBEMoonLake completes patient randomization ahead of schedule..
2023/7/1720:30IHMARKETNEWSMonday’s Wall Street Highlights: Microsoft, Santander,..
2023/6/2818:00GLOBEMoonLake Immunotherapeutics Announces Pricing of $400..
2023/6/2705:01GLOBEMoonLake Immunotherapeutics Announces Proposed Underwritten..
2023/6/2522:00GLOBEMoonLake Immunotherapeutics achieves landmark milestone with..
2023/5/1220:45GLOBEMoonLake Immunotherapeutics Reports First Quarter 2023..

最近閲覧した銘柄

Delayed Upgrade Clock